Skip to main content
logo
Ionis Pharmaceuticals, Inc. (LON:0JDI)
London flag London · Delayed Price · Currency is GBP · Price in USD
77.60
-0.92 (-1.17%)
Dec 19, 2025, 6:38 AM BST

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
SPINRAZA Royalties Revenue
221.90M216.10M
Log In
Log In
Log In
Upgrade
WAINUA Royalties Revenue
43.00M20.20M
Log In
Log In
Log In
Upgrade
TEGSEDI and WAYLIVRA Revenue
36.90M34.20M
Log In
Log In
Log In
Upgrade
Commercial Licensing and Other Royalty Revenue
78.60M22.60M
Log In
Log In
Log In
Upgrade
Total Commercial Revenue
380.40M293.10M
Log In
Log In
Log In
Upgrade
Amortization from Upfront Payments Revenue
-131.40M
Log In
Log In
Log In
Upgrade
Milestone Payments Revenue
-106.40M
Log In
Log In
Log In
Upgrade
R&D License Fees Revenue
-71.30M
Log In
Log In
Log In
Upgrade
Other R&D Services Revenue
-23.50M
Log In
Log In
Log In
Upgrade
Collaborative Agreement Revenue
510.00M332.60M
Log In
Log In
Log In
Upgrade
Eplontersen Joint Development Revenue
76.40M79.40M
Log In
Log In
Log In
Upgrade
Total R&D Revenue
586.40M412.00M
Log In
Log In
Log In
Upgrade
Revenue (Other)
-629.24M-432.16M
Log In
Log In
Log In
Upgrade
Revenue (Total)
966.96M705.14M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.